Home  /  Resource Library  /  Durable Responses with Pembrolizumab in Relapsed/Refractory Mycosis Fungoides and Sezary Syndrome: Final Results from a Phase 2 Multicenter Study

Durable Responses with Pembrolizumab in Relapsed/Refractory Mycosis Fungoides and Sezary Syndrome: Final Results from a Phase 2 Multicenter Study

Results of a phase II trial investigating Pembrolizumab for the treatment of some cutaneous T-cell lymphomas.